Enric Rello
Chief Operating Officer (COO), Chief Financial Off
Management
Oryzon Genomics, Spain
Spain
Biography
Master’s in Administrative Management, Business Administration and Management (ADE) and Degree in Law and Economics from the University Abat Oliba – CEU, Spain. Diploma in Business Studies, University of Barcelona (UB), Spain. Postgraduate in Legal Practice from the ICAB. HBS Finance Excellence Program. Harvard Business School (Executive Education) Boston - USA. Tax technician from Institute of Public Economics, Cooperative and Financial Law at the UB. He began his professional career in the field of consultancy, audit and consulting, later specializing in Management Control and Economic Financial Management in the Environmental and Industrial Machinery (2007 -2011) and Pharmaceutical industry (1993 -2006). In this latter sector he has held the position of Financial Controller, Controller Manager (BPA) and Chief Financial Officer (CFO) in SANDOZ INDUSTRIAL PRODUCTS, S.A. (NOVARTIS). In May 2011 he joined Oryzon as Chief Financial Officer (CFO) and later assumed the responsibilities of Chief Operating Officer (COO). He is a university professor in the Department of Economics and Business at the University Abat Oliba – CEU.
Research Interest
His area of research interest includes: Business Management in Pharmaceutical Technologies, Biotech and Pharmaceutical sciences.
